Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.23) by 82.61 percent. This is a 300 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $17.780 million which missed the analyst consensus estimate of $17.837 million by 0.32 percent. This is a 10.63 percent increase over sales of $16.071 million the same period last year.